Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 137 hits in this display
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
Albumin(Homo sapiens (Human))Molecular Discovery
Curated by ChEMBL
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: 8nMAssay Description:Inhibition of CXCL8-induced chemotaxis in human polymorphonuclear leukocyte pretreated for 15 mins measured after 4 hrs by cell migration assayMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: 50nMAssay Description:The inhibitory effects of candidate compounds on COX-1 and COX-2 were determined using COX inhibitor screening test kits, testing each compound's...More data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: 50nMAssay Description:The inhibitory effects of candidate compounds on COX-1 and COX-2 were determined using COX inhibitor screening test kits, testing each compound's...More data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: 50nMAssay Description:Inhibition of human COX-2 preincubated for 5 mins followed by arachidonic acid substrate addition by colorimetric enzyme immunoassayMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: 150nMAssay Description:Inhibition of ovine COX-1 preincubated for 5 mins followed by arachidonic acid substrate addition by colorimetric enzyme immunoassayMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
IC50: 800nMAssay Description:Inhibition of recombinant human COX2 assessed as reduction in PGF2alpha production using arachidonic acid as substrate by colorimetric methodMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
Transthyretin(Homo sapiens (Human))Leland Stanford Junior University
US Patent
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
IC50: 3.80E+3nMAssay Description:Inhibition of ovine COX1 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition and measured after 2 mins by EIAMore data for this Ligand-Target Pair
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
IC50: 3.90E+3nMAssay Description:Inhibition of ovine COX1 assessed as reduction in PGF2alpha production using arachidonic acid as substrate by colorimetric methodMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: 6.25E+3nMAssay Description:Inhibition of ovine COX1 peroxidase activity assessed as reduction of PGG2 to PGH2 by measuring oxidized TMPD level by colorimetric assayMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: 1.50E+4nMAssay Description:Inhibition of ovine COX2 peroxidase activity assessed as reduction of PGG2 to PGH2 by measuring oxidized TMPD level by colorimetric assayMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: >1.00E+5nMpH: 7.4 T: 2°CAssay Description:Initial rates of 4-nitrophenyl acetate hydrolysis catalyzed by different CA isozymes were monitored spectrophotometrically at 400 nm. A molar absorpt...More data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
IC50: >1.00E+5nMpH: 7.4 T: 2°CAssay Description:Initial rates of 4-nitrophenyl acetate hydrolysis catalyzed by different CA isozymes were monitored spectrophotometrically at 400 nm. A molar absorpt...More data for this Ligand-Target Pair
Transthyretin(Homo sapiens (Human))Leland Stanford Junior University
US Patent
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
IC50: 2.20E+5nMAssay Description:Inhibition of Capra hircus (goat) brain DPP-3 using Arg-Arg-4mbetaNA as substrate assessed as liberation of 4mbetaNA from substrateMore data for this Ligand-Target Pair
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM50174201(ARTHROTEC | GP 45840 | SOLARAZE | Sodium; [2-(2,6-...)
IC50: 1.00E+9nMAssay Description:In vitro inhibition of bovine prostaglandin G/H synthase, using bovine seminal vesicle microsomal preparations; IC50 in umol/LMore data for this Ligand-Target Pair
Transthyretin(Homo sapiens (Human))Leland Stanford Junior University
US Patent
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
Albumin(Homo sapiens (Human))Molecular Discovery
Curated by ChEMBL
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
EC50: 6.30E+4nMAssay Description:Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assayMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
EC50: 2.10E+5nMAssay Description:Agonist activity at human TRPA1 in WI38 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assayMore data for this Ligand-Target Pair
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
EC50: 6.31E+4nMAssay Description:Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assayMore data for this Ligand-Target Pair
Transthyretin(Homo sapiens (Human))Leland Stanford Junior University
US Patent
BDBM13066(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid...)
Kd: 60nMAssay Description:Binding affinity to wild type TTR (unknown origin) expressed in Escherichia coli BL21/DE3 by Circular dichroism spectroscopyMore data for this Ligand-Target Pair
Displayed 1 to 50 (of 137 total ) | Next | Last >>